An adhesion barrier is a medical implant which is used for healing coronary artery after the cardiovascular surgeries. Adhesion barrier are made from oxidized regenerated cellulose, expanded polyterafluorethylene, sodium hylauronate, and carboxymethlcellulose. These barrier act as a physical films, gels, fabrics, or other materials applied between coatings of tissues at the end of a surgery before the slit site is closed. The formation of adhesion can cause infertility, chronic pain, and bowel obstructions are some of the major risks associated during the surgery. The abdominal surgery gives rise to adhesions in large amounts compared to other surgeries.
According to study, “Global Adhesion Barrier Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” some of the key companies operating in the global adhesion barrier market are BaxterInternational Inc., Integra Lifesciences Holdings Corp., Johnson & Johnson (J&J), Medtronic, Sanofi Group, C. R. Bard, Becton dickinson and company, Getinge, Yishengtang, Haohai Biological, Atrium Medical Corp., MAST Biosurgery, Singclean, Anika Therapeutics, Hangzhou Singclean Medical Products Co., Ltd., FzioMed Inc. All the key players are investing on research and development (R&D) for improving adhesion barriers products producing better results.
Based on product, the global adhesion barrier market is segmented into natural adhesion barriers and synthetic adhesion barrier. The natural adhesion barriers include fibrin and collagen & protein and thesynthetic adhesion barriers primarily include regenerated cellulose, hyaluronic acid, polyethylene glycol and others. SprayGel and SprayShield are most commonly used adhesion barriers. The use of Polyethylene glycol based adhesion barrier is expected to register the fast growth over the forecast period owing to properties of biocompatibility & absorbability.
Based on the formulation, market is segmented into gel, film (GynecareInterceed, Seprafilm and Epifilm) or mesh and liquid (Adept and Bio-Gide Perio). The adhesion barrier gels are composed of sodium carboxy methylcellulose and polyethylene oxide, with the protective covering. The use of gels prevents the configuration of post-surgical intrauterine adhesions, some of the gel used as the adhesion barriers are Betamix, DYNAVISC, and Oxiplex/AP. The use of liquid form in adhesion barriers are usually made of high molecular glucose polymers, for instance Icodextrin, which prevents the internal tissue surfaces & organ from adhering to each other during or post-surgery. Based on the application, market is segmented into orthopedic surgeries, gynecological surgeries, cardiovascular surgeries, abdominal general surgeries, urological surgeries, neurological surgeries and others.
The global adhesion barrier market is primarily driven by the rise in geriatric population followed by the increase in prevalence of chronic diseases, and rise in sports-related injuries. However, reluctance towards the use of adhesion barriers among surgeons is one of the biggest factors impacting the growth of market. Moreover, major growth of the market is expected to arise from untapped emerging markets.
Increase over the health concerns have made patients attentive for the use of better healthcare options with the use of advanced care techniques are expected to enhance the global adhesion market over the forecast period. North American region is expected to witness considerable growth of adhesion barrier market owing to rise in demand of technologically advanced healthcare facilities. The Asia-Pacific region is also expected to witness substantial growth owing to increase in population. In 2019, the value of global adhesion barrier market reached at US $820 million and is projected to reach at US $1,310 million, by 2024.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications